132 related articles for article (PubMed ID: 34560683)
1. A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients.
Calvani J; Gérard L; Fadlallah J; Poullot E; Galicier L; Robe C; Garzaro M; Bertinchamp R; Boutboul D; Cuccuini W; Cayuela JM; Gaulard P; Oksenhendler É; Meignin V
Am J Surg Pathol; 2022 Mar; 46(3):353-362. PubMed ID: 34560683
[TBL] [Abstract][Full Text] [Related]
2. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
Foster WR; Bischin A; Dorer R; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
[TBL] [Abstract][Full Text] [Related]
4. Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases.
Pan ZG; Zhang QY; Lu ZB; Quinto T; Rozenvald IB; Liu LT; Wilson D; Reddy V; Huang Q; Wang HY; Ren YS
Am J Surg Pathol; 2012 Aug; 36(8):1129-40. PubMed ID: 22790853
[TBL] [Abstract][Full Text] [Related]
5. Primary effusion lymphoma in Taiwan shows two distinctive clinicopathological subtypes with rare human immunodeficiency virus association.
Chen BJ; Wang RC; Ho CH; Yuan CT; Huang WT; Yang SF; Hsieh PP; Yung YC; Lin SY; Hsu CF; Su YZ; Kuo CC; Chuang SS
Histopathology; 2018 May; 72(6):930-944. PubMed ID: 29206290
[TBL] [Abstract][Full Text] [Related]
6. De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.
AbdullGaffar B; Seliem RM
Int J Surg Pathol; 2018 May; 26(3):266-270. PubMed ID: 28982264
[TBL] [Abstract][Full Text] [Related]
7. KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?
Lambe JS; Oble DA; Nandula SV; Sevilla DW; Colovai AI; Mansukhani M; Chari A; Murty VV; Alobeid B; Bhagat G
Hematol Oncol; 2009 Dec; 27(4):203-10. PubMed ID: 19337983
[TBL] [Abstract][Full Text] [Related]
8. Extracavitary/solid variant of primary effusion lymphoma.
Kim Y; Leventaki V; Bhaijee F; Jackson CC; Medeiros LJ; Vega F
Ann Diagn Pathol; 2012 Dec; 16(6):441-6. PubMed ID: 22497739
[TBL] [Abstract][Full Text] [Related]
9. EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.
Chapman JR; Bouska AC; Zhang W; Alderuccio JP; Lossos IS; Rimsza LM; Maguire A; Yi S; Chan WC; Vega F; Song JY
Br J Haematol; 2021 Sep; 194(5):870-878. PubMed ID: 34272731
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus-8-positive primary effusion lymphoma in HIV-negative patients: Single institution case series with a multidisciplinary characterization.
Rossi G; Cozzi I; Della Starza I; De Novi LA; De Propris MS; Gaeta A; Petrucci L; Pulsoni A; Pulvirenti F; Ascoli V
Cancer Cytopathol; 2021 Jan; 129(1):62-74. PubMed ID: 32975904
[TBL] [Abstract][Full Text] [Related]
11. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
Jiang Y; Xu D; Zhao Y; Zhang L
PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
[TBL] [Abstract][Full Text] [Related]
12. Extracavitary/solid variant of primary effusion lymphoma presenting as a gastric mass.
Liao G; Cai J; Yue C; Qing X
Exp Mol Pathol; 2015 Dec; 99(3):445-8. PubMed ID: 26407759
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells.
Ishikawa E; Kato S; Shimada K; Tanaka T; Suzuki Y; Satou A; Kohno K; Sakakibara A; Yamamura T; Nakamura M; Miyahara R; Goto H; Nakamura S; Hirooka Y
Cancer Med; 2018 Dec; 7(12):6051-6063. PubMed ID: 30449068
[TBL] [Abstract][Full Text] [Related]
14. KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states.
Alexanian S; Said J; Lones M; Pullarkat ST
Am J Surg Pathol; 2013 Feb; 37(2):241-9. PubMed ID: 23282971
[TBL] [Abstract][Full Text] [Related]
15. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in the pericardium: A case with latency type III Epstein-Barr virus infection showing good prognosis without chemotherapy.
Nakamura H; Tsuta K; Nakagawa T; Hirai R; Ota Y
Pathol Res Pract; 2015 Dec; 211(12):1010-3. PubMed ID: 26384578
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.
Sanchez-Martin D; Uldrick TS; Kwak H; Ohnuki H; Polizzotto MN; Annunziata CM; Raffeld M; Wyvill KM; Aleman K; Wang V; Marshall VA; Whitby D; Yarchoan R; Tosato G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376153
[TBL] [Abstract][Full Text] [Related]
17. [ALK-positive large B-cell lymphoma with EBV infection or cyclin D1 expression: a clinicopathological analysis of 3 cases].
Wu WN; Xiang CX; Ma DS; Liu GZ; Liu H
Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):506-511. PubMed ID: 35673721
[No Abstract] [Full Text] [Related]
18. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma.
Goto H; Kojima Y; Nagai H; Okada S
Int J Hematol; 2013 May; 97(5):624-33. PubMed ID: 23605439
[TBL] [Abstract][Full Text] [Related]
20. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.
Kataoka K; Miyoshi H; Sakata S; Dobashi A; Couronné L; Kogure Y; Sato Y; Nishida K; Gion Y; Shiraishi Y; Tanaka H; Chiba K; Watatani Y; Kakiuchi N; Shiozawa Y; Yoshizato T; Yoshida K; Makishima H; Sanada M; Onozawa M; Teshima T; Yoshiki Y; Ishida T; Suzuki K; Shimada K; Tomita A; Kato M; Ota Y; Izutsu K; Demachi-Okamura A; Akatsuka Y; Miyano S; Yoshino T; Gaulard P; Hermine O; Takeuchi K; Ohshima K; Ogawa S
Leukemia; 2019 Jul; 33(7):1687-1699. PubMed ID: 30683910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
